Search
Bristol-Myers Squibb Co
CELG_rAdd to Watchlist
0.089USD
-0.025-21.17%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-21.17%
5 Days
-1.33%
1 Month
-12.06%
6 Months
+11.81%
Year to Date
+23.78%
1 Year
+196.67%
Key Figures
0.119Open
0.119High
12.80KVolume
--P/E TTM
0.00P/E Dynamic
--Dividend TTM
--Turnover Ratio
0.120Prev. Close
0.089Low
997.00Turnover
--P/E Static
--P/B
0.00%Div Yield TTM
--ROA
0.27552wk High
0.57Volume Ratio
--Net Profit
--Shares
--EPS TTM
-0.74Beta
--ROE
0.02352wk Low
25.00%Amplitude
--Gross Margin
0.00Market Cap
0.63Reward/Risk
14.76%Risk Rate
TradingKey Stock Score
No stock score available due to insufficient data.
Bristol-Myers Squibb Co News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Bristol-Myers Squibb Co Info
Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Opdualag (nivolumab and relatlimab-rmbw), Breyanzi (lisocabtagene maraleucel), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), and Sotyktu (deucravacitinib). Its other growth products include Onureg, Inrebic, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension). Opdivo (nivolumab) is a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells.
Ticker SymbolCELG_r
CompanyBristol-Myers Squibb Co
CEOBoerner (Christopher S)
Websitehttps://www.bms.com
Popular Instruments
52857.400
+14.900 (+0.03%)
29676.400
+365.000 (+1.25%)
7507.700
+36.200 (+0.48%)
14971.000
+168.000 (+1.14%)
69741.000
+1593.000 (+2.34%)
6415.700
+62.900 (+0.99%)
68.443
+0.099 (+0.14%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4169.820
+47.910 (+1.16%)
FAQs
What is the current price of Bristol-Myers Squibb Co (CELG_r)?
The current price of Bristol-Myers Squibb Co (CELG_r) is 0.09.
What is the symbol of Bristol-Myers Squibb Co?
The ticker symbol of Bristol-Myers Squibb Co is CELG_r.
What is the 52-week high of Bristol-Myers Squibb Co?
The 52-week high of Bristol-Myers Squibb Co is 0.27.
What is the 52-week low of Bristol-Myers Squibb Co?
The 52-week low of Bristol-Myers Squibb Co is 0.02.
What is the market capitalization of Bristol-Myers Squibb Co?
The market capitalization of Bristol-Myers Squibb Co is 118.71B.
Is Bristol-Myers Squibb Co (CELG_r) currently rated as Buy, Hold, or Sell?
According to analysts, Bristol-Myers Squibb Co (CELG_r) has an overall rating of signal_hold, with a price target of 61.94.